Bodycote sets October 21 vote for 75 percent approval of Bodycote stock

Published on 10/20/2026 at 20:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RBC kept a GBp 933.00 target on October 9, 2026, with a Hold rating. Bodycote stock costs EUR 10.90 on October 20, 2026 at 8:48 p.m. CEST.

Reporting date October 21, 2026

Bodycote set a October 21, 2026 vote requiring 75.00 percent scheme approval.
RBC Capital maintained a Hold rating and a GBp 933.00 target on October 9, 2026.
Bodycote stock costs EUR 10.90 at Lang & Schwarz on October 20, 2026 at 8:48 p.m. CEST.
First-half 2026 revenue reached GBP 381.2 million, up 3.30 percent from GBP 369.0 million.

Aquarellbild einer englischen Industriestadt mit Fabrikgebäuden und Schornsteinen am Fluss — Aquarellmalerei einer britischen Industriestadt mit Fabrikschornsteinen am Fluss, passend zu Bodycote plc, ISIN GB00B3FLWH99, Illustration mit AI erstellt.

Bodycote set October 21, 2026 as the date for shareholder meetings on its recommended Veritas scheme, which requires approval representing at least 75.00 percent of the value voted, according to Financial Times. Bodycote stock was trading at EUR 10.90 at Lang & Schwarz on October 20, 2026 at 8:48 p.m. CEST.

RBC target stays above the quote

RBC Capital maintained a Hold rating and a GBp 933.00 price target in a report dated October 9, 2026, as reported by Markets Insider. The target is 2.58 percent above the GBp 909.50 LSE quote dated October 20, 2026, calculated in the same currency.

Stock sits below its yearly high

Bodycote traded at GBp 909.50 on the London Stock Exchange at 5:00 p.m. BST on October 20, 2026. Its 52-week range was GBp 585.00 to GBp 967.50 on that date, placing the quote 6.00 percent below the high. Trading volume reached 655,645 shares, while the market capitalization was GBP 1.5 billion.

Valuation meets the next dates

The price to earnings ratio stood at 26.75 on October 20, 2026, and the dividend yield was 0.03 percent. Simply Wall St listed a GBP 0.072 per-share dividend for payment on November 5, 2026, after the October 1, 2026 ex-dividend date.

First-half revenue reached GBP 381.2 million

Bodycote reported first-half 2026 revenue of GBP 381.2 million, compared with GBP 369.0 million a year earlier, a 3.30 percent increase. Net income rose to GBP 31.0 million from GBP 27.7 million, while net margin increased to 8.10 percent from 7.50 percent, according to Simply Wall St. The figures give investors a current operating comparison alongside the scheme timetable and the analyst target.

Bodycote stock in market context

The immediate calendar item is the October 21, 2026 Court Meeting and General Meeting. The vote outcome will determine whether the recommended scheme can proceed to the next implementation steps.

The further course of trading is shown by the continuously updated real-time quote of Bodycote stock.